As of September 30, 2026, Acarix AB carries a market capitalization of 240.41M, placing it among publicly traded companies globally. Its enterprise value stands at 219.41M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 240.41M |
| Enterprise Value | 219.41M |
Acarix AB's next confirmed earnings release is scheduled for February 11, 2027.
| Earnings Date | 2/11/2027 |
As of September 30, 2026, Acarix AB has 1.24B shares outstanding.
| Shares Outstanding | 1.24B |
These figures are as of September 30, 2026. The price-to-sales ratio is 23.71, and the price-to-book ratio stands at 6.33.
| PS Ratio | 23.71 |
| PB Ratio | 6.33 |
| P/TBV Ratio | 7.23 |
| P/FCF Ratio | -6.37 |
| P/OCF Ratio | -6.45 |
These figures are as of September 30, 2026. The EV/Sales ratio of 22.55 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 219.41M versus a market cap of 240.41M, with the gap driven by net debt and cash on the balance sheet.
| EV / Sales | 22.55 |
As of September 30, 2026, Acarix AB maintains a current ratio of 10.67, meaning it holds 10.7x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 10.67 |
| Quick Ratio | 6.12 |
| Interest Coverage | -30.19 |
Over the twelve months ended September 30, 2026, Acarix AB posted a negative return on equity (ROE) of -98.54, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -90.22, reflecting losses generated across the asset base. The company generates approximately 1.22M in revenue per employee across its workforce of 8.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 0.28 indicates how many times Acarix AB sells and replaces its inventory over a year, a key working capital efficiency ratio.
| Return on Equity (ROE) | -98.54 |
| Return on Assets (ROA) | -90.22 |
| Revenue Per Employee | 1.22M |
| Employee Count | 8.00 |
| Inventory Turnover | 0.28 |
As of the close on November 17, 2026, Acarix AB's stock has declined approximately 39.19% over the past 52 weeks. The 50-day moving average sits at 0.19, while the 200-day moving average is 0.25.
| 52-Week Price Change | -39.19% |
| 50-Day Moving Average | 0.19 |
| 200-Day Moving Average | 0.25 |
Over the twelve months ended September 30, 2026, Acarix AB generated 9.73M in revenue and converted that into -37.67M in net income, yielding earnings per share of -0.03. EBITDA reached -33.93M, while operating income came in at -37.25M.
| Revenue | 9.73M |
| Gross Profit | 8.08M |
| Operating Income | -37.25M |
| Pretax Income | -37.67M |
| Net Income | -37.67M |
| EBITDA | -33.93M |
| EBIT | -37.25M |
| Earnings Per Share (EPS) | -0.03 |
These figures are as of September 30, 2026. Total book value stands at 37.98M, with working capital of 33.18M providing operational flexibility.
| Cash & Cash Equivalents | 21.00M |
| Net Debt | -21.00M |
| Equity (Book Value) | 37.98M |
| Book Value Per Share | 0.03 |
| Working Capital | 33.18M |
Acarix AB produced -35.79M in operating cash flow over the twelve months ended September 30, 2026. After subtracting -413,000.00 in capital expenditures, free cash flow totaled -36.21M - equivalent to -0.03 per share.
| Operating Cash Flow | -35.79M |
| Capital Expenditures | -413,000.00 |
| Free Cash Flow | -36.21M |
| FCF Per Share | -0.03 |
Over the twelve months ended September 30, 2026, Acarix AB posted a gross margin of 83.02, reflecting its pricing power and cost economics. The operating margin of -382.93 and net profit margin of -387.23 provide insight into operational efficiency.
| Gross Margin | 83.02 |
| Operating Margin | -382.93 |
| Pretax Margin | -387.23 |
| Profit Margin | -387.23 |
| EBITDA Margin | -348.75 |
These figures cover the twelve months ended September 30, 2026. Free cash flow yield is negative at -15.69: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -13.27, meaning Acarix AB raised more capital through share issuance and new debt than it returned via dividends and buybacks.
| Shareholder Yield | -13.27 |
| FCF Yield | -15.69 |
Acarix AB's most recent stock split took place on September 29, 2023 with a 65:72 split ratio.
| Last Split Date | 9/29/2023 |
| Split Ratio | 65:72 |
As of September 30, 2026, Acarix AB has an Altman Z-Score of 13.90, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 13.90 |
Already premium?